At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
BRB Lozengesdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Oral Black Raspberry Administration on Oral Cell DNA Adducts in Smokers
In Brief
A clinical study evaluating BRB Lozenges for Oral Cancer and 3 related conditions. Completed, enrolled 69 participants across 1 site.
Detailed Summary
The purpose of this voluntary research study is to learn about the potential effects that black raspberry (BRB) lozenges may have on reducing the damage caused from cigarette smoke in mouth cells in adult smokers, which may be useful in reducing health risks associated with smoking.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOral Cancer, Smoking, DNA Damage, Oxidative Stress
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartOct 2021
Primary CompletionDec 2024
TodayJul 2026
First PostedMay 4, 2020
Enrollment StartOct 7, 2021
Primary CompletionDec 6, 2024
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 6.2 years ago
Interventions
BRB Lozengesdietary
Each lozenge is made from 1 gram of freeze-dried black raspberry powder (equivalent to \~5 black raspberries) in the form of a dissolvable slow-release lozenge.